BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 22429676)

  • 1. Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer.
    Carrillo SA; Daniel VC; Hall N; Hitchcock CL; Ross P; Kassis ES
    Ann Thorac Surg; 2012 May; 93(5):1621-4. PubMed ID: 22429676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.
    Shin S; Kim HK; Choi YS; Kim K; Kim J; Shim YM
    Ann Thorac Surg; 2013 Sep; 96(3):969-75; discussion 975-6. PubMed ID: 23916803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
    J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
    Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy.
    Pepek JM; Marks LB; Berry MF; Ready NE; Gee NG; Coleman RE; D'Amico TA; Crawford J; Kelsey CR
    Pract Radiat Oncol; 2015; 5(2):79-84. PubMed ID: 25413417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
    Tandberg DJ; Gee NG; Chino JP; D'Amico TA; Ready NE; Coleman RE; Kelsey CR
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):796-801. PubMed ID: 23870158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer.
    Ceylan N; Doğan S; Kocaçelebi K; Savaş R; Çakan A; Çağrici U
    Diagn Interv Radiol; 2012; 18(5):435-40. PubMed ID: 22374706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
    Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
    J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
    Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.